Biotech Executive Search - Frequently Asked Questions

We conduct executive and senior leadership searches across biotech and life sciences, with a particular focus on the roles that define a company's scientific, clinical, regulatory, and commercial trajectory. The positions we place most frequently include:

Executive Leadership

Chief Executive Officer

Chief Scientific Officer

Chief Medical Officer

Chief Financial Officer

Chief Business Officer

Research and Development

Head of Research and Development

VP Clinical Development

VP Clinical Operations

VP Regulatory Affairs

VP/Head of Biostatistics

VP/Head of Biometrics

VP/Head of Data Management

VP/Head of Clinical Data

VP/Head of Medical Affairs

VP/Head of Program Management

VP/Head of Alliance Management

VP/Head of CMC and Manufacturing

Modalities

We have experience placing leaders with expertise across a broad range of modalities, including small molecules, oligonucleotides, biologics, cell and gene therapy, and other emerging platforms.

Therapeutic Areas

Our searches span multiple therapeutic areas, including oncology, rare diseases, neurology, immunology, infectious disease, cardiovascular, metabolic disease, and ophthalmology, among others.

This list reflects our most common placements, not the boundaries of what we do. If you are looking for a senior leader in a function not listed here, the conversation is worth having.

Traditional executive search firms charge up to 33 percent of the executive's first-year cash compensation, meaning the final cost is unknown until an offer is accepted. 

A fixed-fee model replaces that structure with a single, agreed-upon fee established at the start of the engagement, which is typically 25 to 30 percent of first-year base salary, excluding bonuses. You'll know the cost before the search begins, regardless of what the candidate ultimately earns. It also removes a conflict of interest inherent in percentage-based pricing, where a firm's fee grows with the compensation package it helps negotiate.

Genepool Evolution is built on fixed-fee pricing, designed for biotech companies that expect transparency and a search partner whose incentives are aligned with theirs.

Once we engage, we move quickly. Within the first week, we work with you to build a precise profile of the role, covering not just technical qualifications but the leadership style, cultural fit, and business context that define the right candidate. Within one to six weeks, you can expect a curated shortlist of candidates we have spoken with and evaluated against your criteria. We do not present volume. We present candidates who fit.

Throughout the process we provide regular updates on search progress, market feedback, and any adjustments we recommend. Once you identify your preferred candidate, we remain actively involved through interviews, reference checks, offer preparation, and closing. Our commitment extends beyond the placement, staying in contact through the onboarding period to make sure the transition is going well on both sides.

Most biotech executive searches take between eight and sixteen weeks from kickoff to accepted offer, though the timeline varies depending on role complexity, seniority, and market conditions. Internal decision-making often accounts for as much time as the search itself. Companies that move decisively when the right candidate surfaces consistently see better outcomes.

At Genepool Networks, our Natural Selection process is designed to deliver a qualified shortlist within four to six weeks of engagement, with the remaining time focused on evaluation, reference checks, and closing.

The pool of leaders who combine scientific fluency with business acumen and regulatory experience is genuinely small. Biotech is not an industry where strong general managers from other sectors can step in without domain knowledge. At the same time, demand has grown significantly, with the expansion of biotech hubs and a surge in venture-backed startups placing sustained pressure on a talent pool that cannot grow as fast as the industry itself.

The practical result is that the best candidates are rarely looking. They are approached and recruited through trusted networks and direct relationships. Companies that rely on job postings or generalist recruiters to fill senior biotech roles consistently find themselves at a disadvantage.

This is more common than you might expect. Some clients come to us mid-search without finding the right fit. Others want to run a parallel process alongside their own outreach. In either case, we can work with you.

What does not change is our commitment to the quality of the eventual hire. Regardless of how a candidate enters the process, we apply the same rigorous evaluation through our Natural Selection process. Every candidate gets vetted, protecting you from the blind spots that emerge when different candidates are held to different standards.

For many biotech companies, the answer is not always a full-time hire. A consultant can be the smarter move when you need specific expertise for a defined period, when headcount constraints make a permanent hire difficult, or when you want to evaluate a leader before committing to a long-term relationship. Full-time executives make sense when the role is ongoing and when you are building toward a milestone that requires stable, committed leadership.

At Genepool Networks, we place both full-time executives and consulting leaders. If you are uncertain which model fits your situation, that conversation is a good place to start.

Internal talent acquisition teams are often excellent, but executive search at the leadership level presents a different challenge. A dedicated internal recruiter is managing multiple open roles across functions and seniority levels simultaneously. Genepool Networks brings the full weight of its network and sourcing capability to bear on a single mandate, reaching candidates who are not on the market and have no reason to respond to an outreach they did not expect.

The goal is not to replace your internal team. It is to extend their reach into a market that requires a different kind of engagement.

There is no standard answer. Some teams want weekly check-ins. Others prefer to hear from us every time there is something worth reporting. At the start of every engagement, we work with you to establish a cadence that fits your organization and makes sure the right people are informed at the right time.

What you can count on regardless of format is candor. If the search is progressing well, we will tell you. If the market is presenting challenges, we will tell you that too.

Earlier than most companies do. The instinct is often to exhaust internal options first, posting the role, working personal networks, asking board members for referrals, before turning to a search firm. That approach is understandable, but it costs time. In biotech, the cost of a prolonged vacancy at the leadership level is rarely just a line item.

Engaging a search firm early pays dividends when a role is critical to an upcoming milestone, when it requires a rare combination of skills your network is unlikely to surface, or when previous attempts to fill it internally have not produced the right candidate. The best outcomes come when there is enough runway to be thorough and selective about who we bring to you.